This guideline is intended to assist in the planning and execution of studies designed to assess the efficacy of ectoparasiticides for fish. It is the first ectoparasite-specific guideline to deal with studies set in the aquatic environment and therefore provides details for the maintenance of environmental standards for finfish. Information is included on a range of pre-clinical study designs as well as clinical studies in commercial/production sites, set within a regulatory framework. It provides information on the study animals, their welfare, husbandry and environmental requirements during the study. The most commonly pathogenic ectoparasites are presented with relevant points regarding life history, host challenge and numeric evaluation. Preparation and presentation of both topical and oral test treatments is provided, together with guidance on data collection and analysis. The guideline provides a quality standard or efficacy studies on finfish, which will assist researchers and regulatory authorities worldwide and contribute to the wider objective of harmonisation of procedures.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.vetpar.2015.11.003 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Environmental impacts of drugs against parasitic vector-borne diseases and the need to integrate sustainability into their development and use.
Open Res Eur
November 2024
School of Infection and Immunity, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, Scotland, G12 8TA, UK.
Background: The current scientific discourse on environmental impacts of veterinary medicines mostly focuses on ectoparasiticides. Meanwhile, the environmental impacts of widely prescribed drugs for the treatment of human and animal parasitic vector-borne diseases (PVBD) remain largely unexplored. There is thus a need for evidence-based information to support guidelines and protocols for sustainable One Health PVBD drug development and use, while promoting greener research practices.
View Article and Find Full Text PDFEfficacy and Safety of Lotilaner Ophthalmic Solution (0.25%) for the Treatment of Demodex Blepharitis: A GRADE Assessed Systematic Review and Meta-Analysis of Observational & Experimental Studies.
Am J Ophthalmol
August 2024
Department of Nursing, Hamad Medical Corporation (A.J.N.), Doha, Qatar; Department of Public Health, College of Health Sciences, QU Health, Qatar University (A.J.N.), Doha, Qatar. Electronic address:
Article Synopsis
- Several treatments for Demodex blepharitis exist, but they often have undesirable side effects; lotilaner is proposed as a safer alternative.
- A systematic review and meta-analysis, analyzing six relevant studies, determined lotilaner's effectiveness in eradicating Demodex mites.
- Results indicate that lotilaner is not only effective but also well-tolerated, suggesting it could be a promising treatment option for Demodex blepharitis, and consideration of cost-effectiveness is encouraged.
Comparative Evaluation of the Efficacy of Two Ectoparasiticides in Preventing the Acquisition of by and : A Canine Ex Vivo Model.
Microorganisms
January 2024
Ceva Santé Animale, 10 Avenue de la Ballastière, 33500 Libourne, France.
In dogs, tick infestation can cause damage ranging from a simple skin irritation to severe diseases and/or paralysis leading to animal death. For example, and are among the tick species incriminated the most in the transmission of , the agent of human and canine Lyme borreliosis (LB). In this study, we aimed to compare the efficacy of two products designed for dogs-an oral systemic ectoparasiticide and a topical repellent ectoparasiticide-against the acquisition of by adult and using an ex vivo model.
View Article and Find Full Text PDFComparison of the initial and residual speed of Ixodes scapularis kill on dogs treated with a single dose of Bravecto Chew (25 mg/kg fluralaner) or Simparica TRIO (1.2 mg/kg sarolaner, 24 µg/kg moxidectin, 5 mg/kg pyrantel).
Parasit Vectors
November 2023
Department of Statistics, Kansas State University, Manhattan, KS, 66506, USA.
Background: Compliant ectoparasiticide product use is a comprehensive way to control ticks and reduce the risk of tick-borne pathogen transmission to dogs. Because the systemically acting isoxazoline ectoparasiticides require tick attachment for drug delivery, fast speed of kill is essential to minimize tick-borne pathogen transmission risk.
Methods: Dogs of satisfactory tick-carrying capacity were randomly allocated to treatment groups and administered, per label instructions, Bravecto Chews (minimum 25 mg/kg fluralaner), Simparica TRIO (minimum 1.
Topical, contact, and oral susceptibility of adult Culicoides biting midges (Diptera: Ceratopogonidae) to fluralaner.
Parasit Vectors
August 2023
Department of Entomology and Plant Pathology, University of Arkansas, Fayetteville, AR, 72701, USA.
Background: Culicoides biting midges (Diptera: Ceratopogonidae) are economically important blood-feeding pests closely associated with livestock production. They are the principal vectors of two hemorrhagic disease viruses affecting both wild and domestic ruminants within the US: bluetongue virus (BTV) and epizootic hemorrhagic disease virus (EHDV). BTV impacts the US agriculture sector through direct commodity loss and strict international livestock trade restrictions.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!